TLR4 and metabolic dysfunction-associated steatotic liver disease: The LPS/TLR4 signaling pathway has been shown to induce inflammation, mediate OS, participate in IR and liver inflammatory damage as well as fibrosis repair, and play a key role in NAFLD pathogenesis (114).